A detailed history of Dubuque Bank & Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Dubuque Bank & Trust CO holds 36,127 shares of ABBV stock, worth $6.84 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
36,127
Previous 35,352 2.19%
Holding current value
$6.84 Million
Previous $4.76 Million 13.08%
% of portfolio
0.73%
Previous 0.63%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $103,532 - $119,853
775 Added 2.19%
36,127 $5.39 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $107,200 - $133,404
-809 Reduced 2.24%
35,352 $4.76 Million
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $415,464 - $478,469
-2,873 Reduced 7.36%
36,161 $5.76 Million
Q4 2022

Feb 03, 2023

SELL
$138.31 - $165.87 $1.01 Million - $1.21 Million
-7,306 Reduced 15.77%
39,034 $6.31 Million
Q3 2022

Nov 02, 2022

SELL
$134.21 - $153.93 $559,387 - $641,580
-4,168 Reduced 8.25%
46,340 $6.22 Million
Q2 2022

Jul 13, 2022

SELL
$137.62 - $174.96 $251,982 - $320,351
-1,831 Reduced 3.5%
50,508 $7.74 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $567,118 - $703,633
-4,297 Reduced 7.59%
52,339 $8.48 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $191,225 - $241,955
-1,780 Reduced 3.05%
56,636 $7.67 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $154,386 - $175,251
-1,451 Reduced 2.42%
58,416 $6.3 Million
Q2 2021

Jul 09, 2021

SELL
$105.21 - $117.21 $456,190 - $508,222
-4,336 Reduced 6.75%
59,867 $6.74 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $421,885 - $464,444
-4,124 Reduced 6.04%
64,203 $6.95 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $8,451 - $11,410
105 Added 0.15%
68,327 $7.32 Million
Q3 2020

Oct 28, 2020

SELL
$85.91 - $100.83 $339,602 - $398,580
-3,953 Reduced 5.48%
68,222 $5.98 Million
Q2 2020

Jul 24, 2020

SELL
$73.37 - $98.18 $338,749 - $453,297
-4,617 Reduced 6.01%
72,175 $7.09 Million
Q1 2020

Apr 21, 2020

SELL
$64.5 - $97.79 $434,472 - $658,713
-6,736 Reduced 8.06%
76,792 $5.85 Million
Q4 2019

Jan 14, 2020

SELL
$72.13 - $90.25 $613,321 - $767,395
-8,503 Reduced 9.24%
83,528 $7.4 Million
Q3 2019

Oct 10, 2019

BUY
$62.98 - $75.72 $142,271 - $171,051
2,259 Added 2.52%
92,031 $6.97 Million
Q2 2019

Jul 10, 2019

SELL
$65.7 - $83.98 $34,821 - $44,509
-530 Reduced 0.59%
89,772 $6.53 Million
Q1 2019

Apr 02, 2019

BUY
$77.14 - $90.79 $328,230 - $386,311
4,255 Added 4.94%
90,302 $7.28 Million
Q4 2018

Jan 15, 2019

BUY
$77.85 - $96.01 $85,946 - $105,995
1,104 Added 1.3%
86,047 $7.93 Million
Q3 2018

Oct 30, 2018

BUY
$88.91 - $98.84 $190,356 - $211,616
2,141 Added 2.59%
84,943 $8.03 Million
Q2 2018

Jul 17, 2018

BUY
$89.78 - $106.23 $1.56 Million - $1.84 Million
17,325 Added 26.46%
82,802 $7.67 Million
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $2.06 Million - $2.76 Million
22,404 Added 52.01%
65,477 $6.2 Million
Q4 2017

Feb 06, 2018

BUY
$89.56 - $98.21 $3.38 Million - $3.7 Million
37,700 Added 701.66%
43,073 $4.17 Million
Q3 2017

Oct 13, 2017

BUY
$69.85 - $89.22 $375,304 - $479,379
5,373
5,373 $478,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $335B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dubuque Bank & Trust CO Portfolio

Follow Dubuque Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.